Analyst Consensus ?
ConsensusBuy29 ratings
Bullish1862.1%
Neutral1034.5%
Bearish13.4%
FN2 Earnings Intelligence
Willis Towers Watson Public Limited Company (WTW) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 13, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Aug 20, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 19, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Aug 4, 2026 |
| UBS | Buy | Buy | Maintain | Aug 3, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Aug 3, 2026 |
| Citigroup | Neutral | Buy | Downgrade | Aug 3, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 31, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 15, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 9, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 7, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 1, 2026 |
| BMO Capital | Outperform | Market Perform | Upgrade | May 1, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Apr 14, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Sep 22, 2025 |
| Jefferies | Buy | Buy | Maintain | Apr 11, 2025 |
| Roth MKM | Buy | Buy | Maintain | Jul 26, 2024 |
| Stifel | Hold | Hold | Maintain | Feb 7, 2024 |
| Baird | Outperform | Outperform | Maintain | May 1, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Dec 15, 2022 |
| MKM Partners | Buy | Buy | Maintain | Dec 5, 2022 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Oct 19, 2021 |
| Deutsche Bank | Hold | Hold | Maintain | May 3, 2021 |
| CFRA | Buy | Hold | Upgrade | Mar 8, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 10, 2019 |
| William Blair | Market Perform | Outperform | Downgrade | Jan 15, 2018 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Jun 23, 2016 |
| JP Morgan | Underweight | Underweight | Maintain | Feb 9, 2016 |
Upside is calculated against the persisted current price $315.61. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $350 | $327.9 | +10.9% | Aug 19, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $380 | $341.09 | +20.4% | Aug 3, 2026 |
| UBS | Brian Meredith | $405 | $341.04 | +28.3% | Aug 3, 2026 |
| Morgan Stanley | Bob Huang | $315 | $341.39 | -0.2% | Aug 3, 2026 |
| Robert W. Baird | Mark Marcon | $385 | $336.05 | +22.0% | Jul 31, 2026 |
| Mizuho Securities | Yaron Kinar | $406 | $336.05 | +28.6% | Jul 31, 2026 |
| Atlantic Equities | Analyst unavailable | $360 | $287.3 | +14.1% | Jul 15, 2026 |
| Piper Sandler | Paul Newsome | $317 | $288.74 | +0.4% | Jul 15, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $344 | $292.58 | +9.0% | Jul 9, 2026 |
| Mizuho Securities | Analyst unavailable | $361 | $292.58 | +14.4% | Jul 9, 2026 |
| UBS | Analyst unavailable | $382 | $291.47 | +21.0% | Jul 8, 2026 |
| UBS | Analyst unavailable | $374 | $258.12 | +18.5% | Jun 9, 2026 |
| Raymond James | Analyst unavailable | $340 | $261.92 | +7.7% | May 6, 2026 |
| Mizuho Securities | Analyst unavailable | $338 | $259.37 | +7.1% | May 5, 2026 |
| Morgan Stanley | Analyst unavailable | $275 | $259 | -12.9% | May 1, 2026 |
| Robert W. Baird | Mark Marcon | $335 | $260.24 | +6.1% | May 1, 2026 |
| Evercore ISI | Analyst unavailable | $360 | $263.78 | +14.1% | May 1, 2026 |
| Piper Sandler | Paul Newsome | $283 | $256.2 | -10.3% | May 1, 2026 |
| BMO Capital | Analyst unavailable | $300 | $256.2 | -4.9% | May 1, 2026 |
| Truist Financial | Mark Hughes | $320 | $256.33 | +1.4% | Apr 30, 2026 |
| Mizuho Securities | Analyst unavailable | $353 | $285.58 | +11.8% | Apr 13, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $354 | $287.86 | +12.2% | Apr 9, 2026 |
| Piper Sandler | Paul Newsome | $341 | $301.81 | +8.0% | Feb 23, 2026 |
| UBS | Analyst unavailable | $409 | $319.38 | +29.6% | Feb 9, 2026 |
| Truist Financial | Analyst unavailable | $400 | $338.86 | +26.7% | Feb 4, 2026 |
| Mizuho Securities | Analyst unavailable | $392 | $335.1 | +24.2% | Feb 4, 2026 |
| Wells Fargo | Analyst unavailable | $379 | $335.1 | +20.1% | Feb 4, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $345 | $329.28 | +9.3% | Jan 14, 2026 |
| Mizuho Securities | Analyst unavailable | $388 | $327.42 | +22.9% | Jan 14, 2026 |
| Wells Fargo | Elyse Greenspan | $366 | $329.45 | +16.0% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $318 | $331.38 | +0.8% | Jan 8, 2026 |
| Goldman Sachs | Analyst unavailable | $375 | $331.38 | +18.8% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $383 | $333.38 | +21.4% | Jan 7, 2026 |
| Mizuho Securities | Yaron Kinar | $386 | $330.76 | +22.3% | Dec 15, 2025 |
| Wells Fargo | Analyst unavailable | $356 | $325.52 | +12.8% | Dec 12, 2025 |
| Barclays | Alex Scott | $303 | $317.26 | -4.0% | Nov 20, 2025 |
| UBS | Brian Meredith | $398 | $348.68 | +26.1% | Oct 8, 2025 |
| Barclays | Alex Scott | $341 | $349.93 | +8.0% | Oct 8, 2025 |
| Piper Sandler | Analyst unavailable | $387 | $347.07 | +22.6% | Oct 6, 2025 |
| Evercore ISI | Analyst unavailable | $387 | $343.95 | +22.6% | Oct 1, 2025 |
| Wells Fargo | Analyst unavailable | $377 | $342.2 | +19.5% | Sep 30, 2025 |
| Morgan Stanley | Bob Huang | $345 | $329.31 | +9.3% | Aug 18, 2025 |
| Jefferies | Yaron Kinar | $382 | $311 | +21.0% | Dec 20, 2024 |
| Raymond James | Greg Peters | $400 | $331.79 | +26.7% | Dec 5, 2024 |
| Barclays | Alex Scott | $278 | $294.38 | -11.9% | Sep 4, 2024 |
| Wells Fargo | Elyse Greenspan | $321 | $281.52 | +1.7% | Jul 26, 2024 |
| Truist Financial | Mark Hughes | $335 | $280.81 | +6.1% | Jul 26, 2024 |
| CFRA | Catherine Seifert | $315 | $280.96 | -0.2% | Jul 26, 2024 |
| Evercore ISI | David Motemaden | $319 | $277.6 | +1.1% | Jul 25, 2024 |
| BMO Capital | Michael Zaremski | $298 | $272.2 | -5.6% | Feb 12, 2024 |
| Wells Fargo | Jared Shaw | $288 | $247.07 | -8.7% | Jan 11, 2024 |
| BMO Capital | Michael Zaremski | $205 | $203.44 | -35.0% | Aug 8, 2023 |
| Goldman Sachs | Robert Cox | $290 | $237.74 | -8.1% | Feb 27, 2023 |
| Goldman Sachs | Analyst unavailable | $271 | $256.13 | -14.1% | Jan 9, 2023 |
| Raymond James | Analyst unavailable | $280 | $245.24 | -11.3% | Dec 29, 2022 |
| Credit Suisse | Analyst unavailable | $302 | $243.42 | -4.3% | Dec 15, 2022 |
| Citigroup | Analyst unavailable | $247 | $245.63 | -21.7% | Dec 15, 2022 |
| MKM Partners | Analyst unavailable | $285 | $248 | -9.7% | Dec 5, 2022 |
| Morgan Stanley | Analyst unavailable | $240 | $236.06 | -24.0% | Nov 22, 2022 |
| Goldman Sachs | Robert Cox | $227 | $194.85 | -28.1% | Jul 15, 2022 |
Track every rating change on WTW the moment it posts. Free to start.
Start free